Bausch + Lomb Corp
Research Bausch + Lomb Corp (BLCO) on Bullrun: market cap USD 6.16B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBLCO
- ExchangeNYSE
- CountryCanada
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 6.16B
- Financial periodQ2 2026
- RevenueUSD 1.39B
- Net income-USD 14.00M
- Free cash flowUSD 82.00M
- Gross margin62.2%
Valuation Snapshot
latest market cap is USD 6.16B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 5.10B | -USD 360.00M | -USD 66.00M | 59.8% | -1.02 | USD 383.00M | USD 5.05B | USD 6.45B |
| FY2024 | USD 4.79B | -USD 317.00M | -USD 59.00M | 60.9% | -0.9 | USD 305.00M | USD 4.78B | USD 6.47B |
| FY2023 | USD 4.15B | -USD 260.00M | -USD 198.00M | n/a | -0.74 | USD 331.00M | USD 4.56B | USD 6.85B |
| FY2022 | USD 3.77B | USD 6.00M | USD 170.00M | n/a | 0.02 | USD 354.00M | USD 2.44B | USD 7.03B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 6.16B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.05B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 6.36B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 5.99B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.43B | n/a | n/a | n/a |
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bausch + Lomb Corp's market cap?
Bausch + Lomb Corp's market capitalization is USD 6.16B.
What does Bausch + Lomb Corp do?
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing.